Skye Bioscience, Inc.
SKYE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001516551
In the last 90 days, Skye Bioscience, Inc. insiders filed 0 open-market purchases and 3 sales; 42 institutions reported holding it in 13F filings for Q2 2026, worth $11.1M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Skye Bioscience, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −10 vs. Q4 2025
- Shares held
- 16.1M
- +881.0K (+5.8%) vs. Q4 2025
- Total value
- $9.91M
- −$1.52M (−13.3%) vs. Q4 2025
- New holders
- 5
- 9 more added
- Sold out
- 15
- 8 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SKYE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 42 | $11.1M |
| Q1 2026 | 39 | $9.91M |
| Q4 2025 | 50 | $12.1M |
| Q3 2025 | 58 | $78.1M |
| Q2 2025 | 58 | $85.3M |
| Q1 2025 | 75 | $39.3M |
| Q4 2024 | 73 | $71.3M |
| Q3 2024 | 74 | $100.6M |
| Q2 2024 | 62 | $196.3M |
| Q1 2024 | 3 | $31.4M |
| Q4 2023 | 1 | $4.35K |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $253 |
| Q1 2023 | 1 | $207 |
| Q4 2022 | 3 | $193 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 1 | $4.00K |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Skye Bioscience, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| 5AM Venture Management, LLC | 9,681,763 | $5.95M | 1.65% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 2,007,704 | $1.23M | 0.87% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,575,243 | $968.1K | 0.01% | +124,605+8.6% | Added |
| Vanguard Capital Management LLC | 764,457 | $470.1K | 0.00% | +764,457 | New |
| Sphera Funds Management Ltd. | 678,928 | $417.3K | 0.07% | +200,000+41.8% | Added |
| BlackRock, Inc. | 286,131 | $175.9K | 0.00% | +4,290+1.5% | Added |
| Geode Capital Management, LLC | 277,256 | $170.4K | 0.00% | +67,105+31.9% | Added |
| Millennium Management LLC | 258,200 | $158.7K | 0.00% | −122,278−32.1% | Reduced |
| Platinum Investment Management Ltd | 233,095 | $143.3K | 0.04% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 104,229 | $64.1K | 0.00% | +104,229 | New |
| State Street Corp | 75,326 | $46.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 45,762 | $28.1K | 0.00% | +32,476+244.4% | Added |
| XTX Topco Ltd | 40,919 | $25.1K | 0.00% | −12,121−22.9% | Reduced |
| Two Sigma Investments, LP | 25,684 | $15.8K | 0.00% | −26,022−50.3% | Reduced |
| Engineers Gate Manager LP | 20,194 | $12.4K | 0.00% | −2,944−12.7% | Reduced |
| Northern Trust Corp | 20,142 | $12.4K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 18,089 | $11.1K | 0.00% | −3,162−14.9% | Reduced |
| Group One Trading, L.P. | 7,205 | $4.43K | 0.00% | −10,492−59.3% | Reduced |
| Vanguard Global Advisers, LLC | 4,557 | $2.80K | 0.00% | +4,557 | New |
| Morgan Stanley | 2,549 | $1.57K | 0.00% | −1,720−40.3% | Reduced |
| Federated Hermes, Inc. | 1,158 | $712 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 600 | $364 | 0.00% | +598+29,900.0% | Added |
| National Bank of Canada | 400 | $242 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 79 | $51 | 0.00% | +54+216.0% | Added |
| JPMorgan Chase & Co | 66 | $39 | 0.00% | 00.0% | Unchanged |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 52 | $32 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 51 | $31 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 39 | $24 | 0.00% | 00.0% | Unchanged |
| Optiver Holding B.V. | 20 | $12 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 8 | $5 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 3 | $2 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 1 | $1 | 0.00% | −17−94.4% | Reduced |
| McGuire Capital Advisors Inc | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 2 | $1 | 0.00% | +1+100.0% | Added |
| PFS Partners, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2 | $1 | 0.00% | +2 | New |
| Leo H. Evart, Inc. | 1 | $1 | 0.00% | +1 | New |
| Royal Bank of Canada | 127 | $0 | 0.00% | +3+2.4% | Added |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −93,407−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −40,982−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −27,348−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −24,615−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −22,877−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −14,782−100.0% | Sold out |
| Capital Advisors Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,331−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −748−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −586−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −510−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −385−100.0% | Sold out |
| Dynamic Wealth Strategies, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Tucker Asset Management LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |